SEC Form 4 · accession 0001127602-19-008336
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 25 | $144.775 | D | 305,699 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $144.79 | D | 305,199 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.80 | D | 305,099 | D | |
| Common Stock | Feb 25, 2019 | S | 39 | $144.825 | D | 305,060 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.83 | D | 304,960 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.84 | D | 304,860 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.865 | D | 304,760 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $144.87 | D | 304,260 | D | |
| Common Stock | Feb 25, 2019 | S | 700 | $144.88 | D | 303,560 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.8825 | D | 303,460 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.90 | D | 303,360 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.92 | D | 303,160 | D | |
| Common Stock | Feb 25, 2019 | S | 7 | $144.925 | D | 303,153 | D | |
| Common Stock | Feb 25, 2019 | S | 211 | $144.93 | D | 302,942 | D | |
| Common Stock | Feb 25, 2019 | S | 42 | $144.96 | D | 302,900 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.975 | D | 302,800 | D | |
| Common Stock | Feb 25, 2019 | S | 3 | $144.985 | D | 302,797 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.99 | D | 302,597 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $145.00 | D | 302,297 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.015 | D | 302,097 | D | |
| Common Stock | Feb 25, 2019 | S | 6 | $145.03 | D | 302,091 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.04 | D | 301,691 | D | |
| Common Stock | Feb 25, 2019 | S | 3 | $145.045 | D | 301,688 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.